【摘要】：目的:觀察抑肝散治療兒童注意缺陷多動(dòng)障礙(ADHD)陰虛陽(yáng)亢證的臨床療效。方法:將符合本研究納入和排除標(biāo)準(zhǔn)的94例ADHD患者分為對(duì)照組和觀察組各47例。兩組均采用鹽酸哌甲酯片,5 mg/次,2次/d。對(duì)照組服用靜靈口服液,10 m L/次,2次/d。觀察組內(nèi)服抑肝散,1劑/d。兩組療程均為12周。進(jìn)行治療前后斯諾佩評(píng)估(SNAP-Ⅳ)量表(父母版),美國(guó)康納(Conner)設(shè)計(jì)的簡(jiǎn)易多動(dòng)癥行為評(píng)價(jià)量表、韋氏智力量表和陰虛陽(yáng)亢證評(píng)分。結(jié)果:兩組臨床療效經(jīng)Ridit分析,觀察組優(yōu)于對(duì)照組(P0.05);治療后觀察組SNAP-Ⅳ量表和陰虛陽(yáng)亢證評(píng)分低于對(duì)照組(P0.01);治療后觀察組Conner量表學(xué)習(xí)、品行、身心障礙、沖動(dòng)-多動(dòng)、焦慮及多動(dòng)指數(shù)等因子評(píng)分均低于對(duì)照組(P0.01);治療后觀察組韋氏智力量表的言語(yǔ)理解指數(shù)(VCI),知覺推理指數(shù)(PRI),工作記憶指數(shù)(WMI),加工速度指數(shù)(PSI),一般能力指數(shù)(GAI),認(rèn)知熟練指數(shù)(CPI),總智商(FSIQ)等因子評(píng)分均高于對(duì)照組(P0.01)。結(jié)論:抑肝散配合鹽酸哌甲酯片能降低ADHD兒童陰虛陽(yáng)亢證,SNAP-Ⅳ評(píng)定量表和Conner行為評(píng)價(jià)量表各因子評(píng)分,并能升高韋氏智力量表各因子評(píng)分,能改善ADHD的癥狀,提高患者的智力水平,臨床療效優(yōu)于靜靈口服液。
[Abstract]:Objective: to observe the clinical effect of Yigan Powder on children with attention deficit hyperactivity disorder (ADHD). Methods: 94 patients with ADHD were divided into control group (n = 47) and observation group (n = 47). Both groups were treated with methylphenidate hydrochloride tablets for 5 mg/, twice a day. The control group was treated with Jingling oral liquid, 10 mL / time, twice a day. The observation group was treated with Yigan Powder, 1 dose per day. The course of treatment was 12 weeks in both groups. Before and after treatment, the scale of SNAP- 鈪，

本文編號(hào)：2330735